Unibest
← Back to patent-cliff list

CAS 676129-92-3

(S)-2-(((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylbutanoic acid

Codes: VALS-011

Application context (from source-drug indications)

HypertensionLevamlodipine Besylate/ValsartanEssential hypertensionLevamlodipine Besylate/ValsartanEssential hypertensionValsartan/Amlodipine OrotateEssential hypertensionValsartan/Lercanidipine HydrochlorideLeft ventricular dysfunctionValsartanHypertensionValsartanEssential hypertensionValsartanPulmonary arterial hypertensionValsartanRight ventricular dysfunctionValsartanPost-myocardial infarction syndromeValsartan

Source drugs (routes using this intermediate)

DrugTierExpiry
Levamlodipine Besylate/ValsartanTier C — Watch / trade-
Valsartan/Amlodipine OrotateTier C — Watch / trade-
Valsartan/Lercanidipine HydrochlorideTier C — Watch / trade-
ValsartanTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Levamlodipine Besylate/ValsartanOptimised routesteps: 3total yield: /
Valsartan/Amlodipine OrotateOptimised routesteps: 3total yield: /
Valsartan/Lercanidipine HydrochlorideOptimised routesteps: 3total yield: /
ValsartanOptimised routesteps: 3total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.